LAS VEGAS—A subset of breast cancer patients with metastases in the lung and/or liver may benefit from surgical or ablative intervention, according to a recent study. A hypothesis constantly discussed is whether intervention at the metastatic site will slow or avert systemic spread by eliminating resistant clones. Researchers in a recent study further hypothesized that surgical intervention may also eliminate reseeding from the metastatic site.
“The development of